Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
4DMedical Ltd ( (AU:4DX) ) just unveiled an announcement.
4DMedical Limited announced the expiry of its listed options, exercisable at $1.365, on 31 December 2025. The official quotation of these options will cease on 23 December 2025. This announcement is significant for stakeholders as it provides a deadline for exercising options, potentially impacting investor decisions and the company’s financial strategy.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is a global medical technology company specializing in advanced imaging and artificial intelligence for respiratory care. The company offers innovative solutions such as the FDA-cleared XV Lung Ventilation Analysis Software and the CT:VQ solution, which enhance physician productivity and enable personalized patient care through a Software-as-a-Service model. 4DMedical’s technologies aim to transform standard scans into functional insights for early detection and precise monitoring of lung diseases.
Average Trading Volume: 7,906,330
Technical Sentiment Signal: Buy
Current Market Cap: A$882.4M
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.